Prestige Consumer Healthcare (PBH) Return on Sales (2010 - 2025)

Prestige Consumer Healthcare's Return on Sales history runs 16 years deep, the most recent figure standing at 0.0% for Q4 2025.

• On a quarterly basis, Return on Sales changed 0.0% year-over-year to 0.0% in Q4 2025; TTM through Dec 2025 was 0.0%, a 0.0% change from a year earlier, with the FY2025 full-year figure at 0.0%, changed 0.0% from the prior year.
• Return on Sales climbed to 0.0% in Q4 2025 per PBH's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.0% in Q2 2021 and bottomed at 0.01% in Q1 2023.
• The 5-year median for Return on Sales is 0.0% (2023), against an average of 0.0%.
• Across the five-year window, Return on Sales declined 1 bps in 2023 and climbed 1 bps in 2024, its largest moves.
• Year by year, Return on Sales stood at 0.0% in 2021, then advanced by 3 bps to 0.0% in 2022, then fell by 0 bps to 0.0% in 2023, then gained by 12 bps to 0.0% in 2024, then fell by 22 bps to 0.0% in 2025.
• Per Business Quant, the three latest PBH Return on Sales figures stand at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).